Hyskon induced pulmonary hemorrhage - 12/09/11
Doi : 10.1016/0952-8180(95)00035-G
Robby M. Romero, MD 
, Joel M. Kreitzer, MD ⁎, †, George V. Gabrielson, MD †
, Joel M. Kreitzer, MD ⁎, †, George V. Gabrielson, MD † Department of Anesthesiology, The Mount Sinai Medical Center, New York, NY, USA
Address reprint requests to Dr. Kreitzer at the Department of Anesthesiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1192, New York, NY 10029, USA.Abstract |
Hyskon®, a distension medium composed of dextran 70 in 10% dextrose in water, is often used during hysteroscopic procedures. Coagulopathy and pulmonary edema are the most commonly reported side effects encountered during its use. We present the first case report in which a healthy patient developed pulmonary hemorrhage from Hyskon® use. The major side effects of Hyskon® are discussed, as are the possible etiologies of the reported complication and the implications for anesthesiologists.
Le texte complet de cet article est disponible en PDF.Keywords : Coagulopathy, dextran, hemoptysis
© 1995
Publié par Elsevier Masson SAS.
Vol 7 - N° 4
P. 323-325 - juin 1995 Retour au numéro
Article précédent
- Arterially misplaced Swan-Ganz catheter in a hypotensive and hypoxic COPD patient
- Tai-Shion Lee, Yaw Wu
- Pharmacologic drugs for controlled hypotension
- Lisa D. Testa, Joseph D. Tobias
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?